Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.
P/E ratio for Shin Poong Pharm.Co.,Ltd. (019170.KS)
P/E ratio as of 2023: -12.31
According to Shin Poong Pharm.Co.,Ltd.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -12.31. At the end of 2022 the company had a P/E ratio of -29.76.
P/E ratio history for Shin Poong Pharm.Co.,Ltd. from 2007 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -12.31 |
| 2022 | -29.76 |
| 2021 | -142.10 |
| 2020 | 1247.45 |
| 2019 | 67.96 |
| 2018 | 111.79 |
| 2017 | 435.62 |
| 2016 | -15.54 |
| 2015 | 100.72 |
| 2014 | 52.49 |
| 2013 | 32.66 |
| 2012 | 13.93 |
| 2011 | 6.64 |
| 2010 | 5.16 |
| 2009 | 4.42 |
| 2008 | 5.50 |
| 2007 | 10.34 |